BioHealth News Archive
BIO comments on NIST proposal to use march-in rights for price controls
Contention over the Bayh-Dole march-in rights provision is in the news again. The National Institute of Standards and Technology (NIST) proposes using the process…
Read More
Biden-Harris Administration’s ARPA-H commits $100 million to accelerate women’s health research
First Lady Jill Biden announces funding as first major deliverable from new White House Initiative on Women’s Health Research As the first major deliverable…
Read More
TEDCO Generates $2.7 Billion in Economic Benefits for Maryland’s Ecosystem in 2023, According to Independent Study
COLUMBIA, Md. (February 21, 2024) – TEDCO, Maryland’s economic engine for technology companies, announced the findings of an independent economic impact study detailing the contributions of…
Read More
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
GAITHERSBURG, Md., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global company providing solutions that address public health threats and delivering life-extending products to…
Read More
Fierce Biotech: NIH to invest another $515M over 4 years for long COVID research
The National Institutes of Health is investing $515 million more into long COVID research efforts, three years after launching the initiative with $1.15 billion. The…
Read More
WBJ: New CEO at Children’s National lays out her vision
By Sara Gilgore – Staff Reporter, Washington Business Journal - Feb 15, 2024 - It was her mother’s 86th birthday when Michelle Riley-Brown received a call that…
Read More
Children’s National performs first ever HIFU procedure on patient with cerebral palsy
In January, a team of multidisciplinary doctors performed the first case in the world of using bilateral high intensity focused ultrasound (HIFU) pallidotomy on Jesus, a…
Read More
Waisman Biomanufacturing and RoosterBio Announce Collaboration for GMP Manufacturing of Cell and Exosome Therapies
FREDERICK, Md., Feb. 13, 2024 /PRNewswire-PRWeb/ -- Waisman Biomanufacturing, a leading contract development and manufacturing organization (CDMO) which is strategically part of the University of Wisconsin Madison,…
Read More
Career Opportunity with BHI: Life Sciences Business Strategist
BioHealth Innovation (BHI) is an innovation intermediary that facilitates the commercialization of emerging technologies in the BioHealth Capital Region (Maryland, DC and Virginia). We…
Read More
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (“CEL-SCI” or the “Company”) (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced the pricing of an offering of 3,875,000…
Read More
CityBiz+ – Biosim AI
Biosim AI, founded by a professor at the University of Maryland in College Park, has closed on $12.25 million in its bid to commercialize technology to “enable…
Read More
Amarex Celebrates Its 25th Anniversary
Germantown, MD, USA (February 07, 2024) – Amarex Clinical Research, LLC, an NSF company, announces December 2023 marked its 25th year advancing patient access…
Read More
I-Mab Signs Agreement to Divest its Assets and Business Operations in China to Become Rockville-Based Biotech
ROCKVILLE, Md., Feb. 7, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a global biotech company exclusively focused on bringing highly differentiated immunotherapies and biologics for cancer treatment to…
Read More
BHI Remembers Dr. William G. Hearl: A Pillar of the BioHealth Capital Region
BioHealth Innovation (BHI) deeply mourns the loss of Dr. William G. Hearl, a former BHI Board member and a prominent contributor to the BioHealth…
Read More
BullFrog AI Announces Closing Of $5.7M Public Offering
GAITHERSBURG, Md., Feb. 05, 2024 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company…
Read More